These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3606073)

  • 1. Effect of orally administered activated charcoal on vancomycin clearance.
    Davis RL; Roon RA; Koup JR; Smith AL
    Antimicrob Agents Chemother; 1987 May; 31(5):720-2. PubMed ID: 3606073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of oral activated charcoal on tobramycin clearance.
    Davis RL; Koup JR; Roon RA; Opheim KE; Smith AN
    Antimicrob Agents Chemother; 1988 Feb; 32(2):274-5. PubMed ID: 3364947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oral activated charcoal on vancomycin clearance in rabbits with acute renal failure.
    el-Sayed YM; Niazy EM; Tawfik AF; al-Dardiri MM
    Drugs Exp Clin Res; 1993; 19(1):19-24. PubMed ID: 8223136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of orally administered activated charcoal on ciprofloxacin pharmacokinetics in healthy volunteers.
    Torre D; Sampietro C; Quadrelli C; Bianchi W; Maggiolo F
    Chemioterapia; 1988 Dec; 7(6):382-6. PubMed ID: 3219749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceleration of the body clearance of phenobarbital by oral activated charcoal.
    Berg MJ; Berlinger WG; Goldberg MJ; Spector R; Johnson GF
    N Engl J Med; 1982 Sep; 307(11):642-4. PubMed ID: 7050705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum theophylline clearance with orally administered activated charcoal.
    Mahutte CK; True RJ; Michiels TM; Berman JM; Light RW
    Am Rev Respir Dis; 1983 Nov; 128(5):820-2. PubMed ID: 6638669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceleration of digoxin clearance by activated charcoal.
    Lalonde RL; Deshpande R; Hamilton PP; McLean WM; Greenway DC
    Clin Pharmacol Ther; 1985 Apr; 37(4):367-71. PubMed ID: 3978996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated oral doses of activated charcoal and the clearance of tobramycin, a non-absorbable drug.
    Watson WA; Jenkins TC; Velasquez N; Schentag JJ
    J Toxicol Clin Toxicol; 1987; 25(3):171-84. PubMed ID: 3612896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral activated charcoal and dapsone elimination.
    Neuvonen PJ; Elonen E; Mattila MJ
    Clin Pharmacol Ther; 1980 Jun; 27(6):823-7. PubMed ID: 7379451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oral charcoal and urine pH on dextropropoxyphene pharmacokinetics.
    Kärkkäinen S; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):219-25. PubMed ID: 2987139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated clearance of intravenously administered theophylline and phenobarbital by oral doses of activated charcoal in rats. A possibility of the intestinal dialysis.
    Arimori K; Nakano M
    J Pharmacobiodyn; 1986 May; 9(5):437-41. PubMed ID: 3761133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oral activated charcoal on the pharmacokinetics of quinidine and quinine administered intravenously to rabbits.
    Hasan MM; Hassan MA; Rawashdeh NM
    Pharmacol Toxicol; 1990 Jul; 67(1):73-6. PubMed ID: 2395819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral charcoal and urine pH on sotalol pharmacokinetics.
    Kärkkäinen S; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):441-6. PubMed ID: 6092287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple-dose activated charcoal in an accidental vancomycin overdose.
    Kucukguclu S; Tuncok Y; Ozkan H; Guven H; Uguz A; Maltepe F
    J Toxicol Clin Toxicol; 1996; 34(1):83-6. PubMed ID: 8632518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of orally administered activated charcoal on intestinal dialysis of intravenously administered M79175, an aldose reductase inhibitor, in rats.
    Arimori K; Mishima M; Iwaoku R; Nakano M
    J Pharmacobiodyn; 1987 Jun; 10(6):243-9. PubMed ID: 3118006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of oral activated charcoal on imipramine clearance.
    Goldberg MJ; Park GD; Spector R; Fischer LJ; Feldman RD
    Clin Pharmacol Ther; 1985 Sep; 38(3):350-3. PubMed ID: 4028632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of the effect of repeated doses of oral activated charcoal on salicylate elimination.
    Ho JL; Tierney MG; Dickinson GE
    J Clin Pharmacol; 1989 Apr; 29(4):366-9. PubMed ID: 2723125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exchange transfusion and multidose activated charcoal following vancomycin overdose.
    Burkhart KK; Metcalf S; Shurnas E; O'Meara O; Brent J; Kulig K; Rumack BH
    J Toxicol Clin Toxicol; 1992; 30(2):285-94. PubMed ID: 1588677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do gastric contents modify antidotal efficacy of oral activated charcoal?
    Olkkola KT; Neuvonen PJ
    Br J Clin Pharmacol; 1984 Nov; 18(5):663-9. PubMed ID: 6508975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal dialysis of disopyramide in healthy subjects.
    Arimori K; Kawano H; Nakano M
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):280-4. PubMed ID: 2737797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.